Arbutus Biopharma Reports Q3 2026 Earnings: EPS Hits $0.30, Revenue Falls to $0. ...

GuruFocus | Nov 10, 2026 9:50 AM EST

Q3 2026 Net Income of $59.1M Driven by Genevant Dividend and Moderna Settlement Proceeds Related Stocks: ABUS ,